Abstract
Scleral devices can play a vital role in the treatment of ocular surface disease, both as an adjunct to traditional therapy and as an alternative when traditional therapies fail. With proper utilization, gas-permeable scleral lenses can promote healing of the ocular surface and improve debilitating symptoms related to severe dry eye syndrome secondary to conditions such as GVHD or Sjogren’s syndrome as well as persistent epithelial defects. Scleral lenses can also provide a safer alternative to surgery for patients with corneal irregularity who can no longer tolerate traditional gas-permeable corneal lenses. Scleral lenses and PROSE devices should be considered in all of these situations when traditional treatment modalities have failed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jacobs DS, Rosenthal P. Boston scleral lens prosthetic device for treatment of severe dry eye in chronic graft-versus-host disease. Cornea. 2007;26(10):1195–9. doi:10.1097/ICO.0b013e318155743d.
Schornack MM, Baratz KH, Patel SV, Maguire LJ. Jupiter scleral lenses in the management of chronic graft versus host disease. Eye Contact Lens. 2008;34(6):302–5. doi:10.1097/ICL.0b013e318188e205.
Lee SJ, Vogelsang G, Flowers MED. Chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2003;9(4):215–33. doi:10.1053/bbmt.2003.50026.
Lin X, Cavanagh H. Ocular manifestations of graft-versus-host disease: 10 years’ experience. Clin Ophthalmol. 2015;9:1209–13.
Westeneng AC, Hettinga Y, Lokhorst H, Verdonck L, van Dorp S, Rothova A. Ocular graft-versus-host disease after allogeneic stem cell transplantation. Cornea. 2010;29(7):758–63. doi:10.1097/ICO.0b013e3181ca321c.
Allan EJ, Flowers MED, Lin MP, Bensinger RE, Martin PJ, Wu MC. Visual acuity and anterior segment findings in chronic graft-versus-host disease. Cornea. 2011;30:1392–7. doi:10.1097/ICO.0b013e31820ce6d0.
Nassar A, Tabbara KF, Aljurf M. Ocular manifestations of graft-versus-host disease. Saudi J Ophthalmol. 2013;27(3):215–22. doi:10.1016/j.sjopt.2013.06.007.
Schornack MM, Pyle J, Patel SV. Scleral lenses in the management of ocular surface disease. Ophthalmology. 2014;121(7):1398–405. doi:10.1016/j.ophtha.2014.01.028.
Russo PA, Bouchard CS, Galasso JM. Extended-wear silicone hydrogel soft contact lenses in the management of moderate to severe dry eye signs and symptoms secondary to graft-versus-host disease. Eye Contact Lens. 2007;33(3):144–7. doi:10.1097/01.icl.0000244154.76214.2d.
Inamoto Y, Sun Y-C, Flowers MED, et al. Bandage soft contact lenses for ocular graft-versus-host disease. Biol Blood Marrow Transplant. 2015;21(11):2002–7.
Yoo S-E, Lee D-C, Chang M-H. The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. Korean J Ophthalmol. 2005;19:258–63. doi:10.3341/kjo.2005.19.4.258.
Foulks GN, Borchman D, Yappert MC, Kakar S. Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study. Cornea. 2013;32(1):44–53. doi:10.1097/ICO.0b013e318254205f.
Luchs J. Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis. Adv Ther. 2008;25(9):858–70. doi:10.1007/s12325-008-0096-9.
Schornack MM, Patel SV. Scleral lenses in the management of keratoconus. Eye Contact Lens. 2010;36(1):39–44. doi:10.1097/ICL.0b013e3181c786a6.
Lee JC, Chiu GB, Bach D, Bababeygy SR, Irvine J, Heur M. Functional and visual improvement with prosthetic replacement of the ocular surface ecosystem scleral lenses for irregular corneas. Cornea. 2013;32:1540–3. doi:10.1097/ICO.0b013e3182a73802.
DeLoss KS, Fatteh NH, Hood CT. Prosthetic replacement of the ocular surface ecosystem (PROSE) scleral device compared to keratoplasty for the treatment of corneal ectasia. Am J Ophthalmol. 2014;158(5):974–982.e2. doi:10.1016/j.ajo.2014.07.016.
Pecego M, Barnett M, Mannis MJ, Durbin-Johnson B. Jupiter scleral lenses: the UC Davis eye center experience. Eye Contact Lens. 2012;38(3):179–82. doi:10.1097/ICL.0b013e31824daa5e.
Baran I, Bradley JA, Alipour F, Rosenthal P, Le HG, Jacobs DS. PROSE treatment of corneal ectasia. Cont Lens Anterior Eye. 2012;35(5):222–7. doi:10.1016/j.clae.2012.04.003.
Katzman LR, Jeng BH. Management strategies for persistent epithelial defects of the cornea. Saudi J Ophthalmol. 2014;28(3):168–72. doi:10.1016/j.sjopt.2014.06.011.
Ciralsky JB, Chapman KO, Rosenblatt MI, et al. Treatment of refractory persistent corneal epithelial defects: a standardized approach using continuous wear PROSE therapy. Ocul Immunol Inflamm. 2014;23(3):219–24. doi:10.3109/09273948.2014.894084.
Lim P, Ridges R, Jacobs DS, Rosenthal P. Treatment of persistent corneal epithelial defect with overnight wear of a prosthetic device for the ocular surface. Am J Ophthalmol. 2013;156(6):1095–101. doi:10.1016/j.ajo.2013.06.006.
Acknowledgments
Financial Disclosures: None of the authors have any financial disclosures regarding the contents discussed in this manuscript. Conflict of Interest: None of the authors have any conflicts of interest with the contents discussed in this manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Shorter, E., Butcko, V. (2018). Scleral Lenses in the Management of Ocular Surface Disease. In: Djalilian, A. (eds) Ocular Surface Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-15823-5_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-15823-5_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-15822-8
Online ISBN: 978-3-319-15823-5
eBook Packages: MedicineMedicine (R0)